Horizon Therapeutics Public Company Investor Relations Material
Latest events
Q3 2022
Horizon Therapeutics Public Company
Investor Presentation
8 Aug, 2023
Q2 2023
8 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Horizon Therapeutics Public Limited Company
Access all reports
Horizon Therapeutics Public Limited Company was a biopharmaceutical company focused on the development and commercialization of treatments for rare, autoimmune, and severe inflammatory diseases. The company marketed a portfolio of therapies in North America and internationally. Horizon Therapeutics Public Limited Company was headquartered in Dublin, Ireland, and its shares were listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
HZNP
Country
🇺🇸 United States